Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)
Listen to this summary
The authors aimed to determine whether ivermectin improves outcomes for critically and noncritically ill hospitalized patients with COVID-19. The study found that ivermectin did not significantly enhance organ support-free days or hospital survival compared to the control group in both critically and noncritically ill patients, suggesting that it is unlikely to provide clinical benefit in this population.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Critical care medicine
View all →May 6, 2026 · Critical care medicine
Household Income Decline and Job Loss Among Survivors of Critical Illness: A Nationwide Cohort Study
Apr 23, 2026 · Critical care medicine
Use of Structured Exercise Program with Resistance Training and Verticalization in Adults on Extracorporeal Membrane Oxygenation: A Prospective Pilot Study
Apr 23, 2026 · Critical care medicine
Effects of Early Versus Delayed Mechanical Thrombectomy on Outcomes in Intermediate-Risk Acute Pulmonary Embolism
Apr 16, 2026 · Critical care medicine
Disparities in Finding Delirium in Critically Ill Latinos
Apr 13, 2026 · Critical care medicine
The Impact of Cultural and Linguistic Diversity on Sepsis Outcomes in Patients Admitted to ICUs: A Multicenter, Retrospective Cohort Study
Apr 8, 2026 · Critical care medicine
The Influence of Older Age on RBC Transfusion Decisions in ICU Patients
More in Internal Medicine
View all →May 10, 2026 · JAMA
Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial
May 10, 2026 · European heart journal
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 10, 2026 · European heart journal
Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial
May 10, 2026 · JAMA
Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
